Natco Pharma's Hyderabad unit gets 7 USFDA Form 483 observations

Natco Pharma announced on Thursday that it received a Form 483 from the United States Food and Drug Administration (USFDA) with seven observations following an inspection of its pharmaceutical division in Hyderabad...

Role of Optical Imaging in Early Cancer Detection and Treatment

In an interaction with India Pharma Outlook, Dr. Ganesh Babu, Head of Clinical and Regulatory Affairs at Carl Zeiss India, discusses how optical imaging technologies like fluorescence imaging and OCT are revolutionizing cancer detection. He highlight

India's Pharma Sector Faces Heightened FDA Scrutiny on Quality

India's domestic pharmaceutical industry will be subject to heightened scrutiny in light of ongoing quality control issues among domestic manufacturers, a reported by BMI stated...

Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks

Eli Lilly's experimental obesity drug, eloralintide, has shown promising early-stage data supporting weight loss of an average of 11.5 percent after only 12 weeks, said an investor note from Cantor Fitzgerald...

India's Diagnostic Labs Gear Up Amid Fresh Wave of Covid Infections

Leading diagnostic chains in India are scaling up operations amid a sharp rise in Covid-19 cases, driven by new variants such as JN.1, NB.1.8.1, and LF.7. According to diagnostic labs, RT-PCR tests have risen by 70 percent as people become more aware

Health Ministry Proposes Ban on 34 Antimicrobials in Animal Use

The Union Health Ministry has issued a draft notification proposing a ban on the manufacture, import, sale, and distribution of 34 antimicrobials

NABL Pushes Accredited Labs to Use Combined ILAC MRA Mark for Global Trust

The National Accreditation Board for Testing and Calibration Laboratories (NABL) is encouraging its accredited Conformity Assessment Bodies

Bayer Tests GIRK4 Inhibitor in Phase I Study for AFib Care

Bayer has initiated a Phase I clinical trial for BAY 3670549, a first-in-class, highly selective G-protein-coupled inwardly rectifying potassium channel 4 (GIRK4) inhibitor, targeting atrial fibrillation (AFib)...

Bharat Biotech's Hillchol Clears Phase-III Cholera Vaccine Trials

Bharat Biotech International Ltd announced that it successfully completed Phase III clinical trials for its oral cholera vaccine, Hillchol. The double-blind, randomized study evaluated Hillchol for safety, immunogenicity, and consistency, and...

Unicommerce to Streamline Tata 1mg's Online Order System

Tata 1mg has partnered with Unicommerce, a leading e-commerce enablement SaaS platform in India, to boost its order processing and logistics capabilities. Through this collaboration, Tata 1mg aims to automate and streamline its backend operations...

© 2025 India Pharma Outlook. All Rights Reserved.

Safety Monitoring